T1	Participants 376 430	in patients previously treated with a fluoropyrimidine
T2	Participants 620 660	patients with advanced colorectal cancer
T3	Participants 1264 1324	randomised 44 patients to combination and 45 to single agent
T4	Participants 1326 1424	Eight patients in the irinotecan arm and 4 in the combination arm had grade 3/4 diarrhoea (P=0.24)
